VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1747551
Sex: M
Age: 33
State: NC

Vax Date: 09/28/2021
Onset Date: 09/28/2021
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Pt has reported tingling in arm of where vaccine was administered. Told to F/U with provider. Pt was worried about effect but other than tingling heis feeling completly fine. had a little bit of nauseau. Will call if there is any update

Other Meds:

Current Illness:

ID: 1747552
Sex: F
Age: 41
State: MN

Vax Date: 03/25/2021
Onset Date: 09/29/2021
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: 9/29 SARS/COV-2, NAAT, positive

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Breakthrough COVID

Other Meds:

Current Illness:

ID: 1747553
Sex: F
Age: 50
State: WV

Vax Date: 09/16/2021
Onset Date: 09/26/2021
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Headache-Mild

Other Meds:

Current Illness:

ID: 1747554
Sex: F
Age: 62
State: IA

Vax Date: 09/25/2021
Onset Date: 09/25/2021
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Systemic: already received J and J and did not tell pharmacy, Additional Details: pt received dose of J & J in April 2021 from another pharmacy. Did not report when making appointment for Pfizer

Other Meds:

Current Illness:

ID: 1747555
Sex: M
Age: 32
State: VA

Vax Date: 09/26/2021
Onset Date: 09/26/2021
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Rash Generalized-Severe, Systemic: Abdominal Pain-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Joint Pain-Medium, Systemic: Lymph Node Swelling-Medium, Systemic: Nausea-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Severe, Systemic: Weakness-Medium, Additional Details: Patient came in pharmacy on 09/29/21 around 9am and shared with pharmacist he experienced severed bilateral arm pain, enlarged rash localized to arm site where vaccine was administered, neurologic pain , burning/ tingling of extermities, inflammation/swollen lymph nodes, and pericarditis symptoms. pharmacist instructed him to contact dr and share symptoms and adverse reaction to moderna vaccine given on sunday. He shared he would and would follow up. patient stated better feelin

Other Meds:

Current Illness:

ID: 1747556
Sex: F
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: miscarriage; vaccinated with GARDASIL-9 and subsequently had fertility issues/She had a miscarriage; This spontaneous prospective pregnancy report was received from a medical student via a company representative referring to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route, strength, lot # and expiration date were not reported) for prophylaxis. Subsequently the patient had fertility issues. She had a miscarriage (vaccine exposure during pregnancy). The last menstrual period (LMP) the estimated date of delivery (EDD) was not provided. The pregnancy outcome was miscarriage and the fetal outcome was congenital anomaly. The causality between hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) and abortion induced was not provided. Upon internal review, the miscarriage was determined to be medically significant. The case is cross referenced to the case 2109USA006148 due to Parent-Child Link. ; Sender's Comments: US-009507513-2109USA006148:

Other Meds:

Current Illness:

Date Died:

ID: 1747559
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Disseminated Measles; This literature marketed information has been received from the authors in a published article title as stated below and refers to a 17-year-old female patient. The patient's concurrent conditions included Hodgkin's lymphoma. On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (MMR) (Manufacturer unknown) (lot #, expiration date, dose, strength, route of administration and anatomical location of vaccine were not reported) a for prophylaxis. In 2019, she was admitted into the hospital for febrile neutropenia that developed during her third cycle of chemotherapy. A neck mass was noted on examination, and chest radiography showed a mediastinal mass. She was transferred to another hospital, where a biopsy led to a diagnosis of Hodgkin's lymphoma of the nodular sclerosing type. Because her mother lived away, she was transferred to our institution for further evaluation and treatment. Her lymphoma was stage IIA, and doxorubicin hydrochloride (ADRIAMYCIN) (+) bleomycin (+) vincristine sulfate (+) etoposide phosphate (+) prednisone (+) and cyclophosphamide (ABVE-PC) chemotherapy was initiated urgently, owing to tracheal compression from the mediastinal mass. She received three rounds of chemotherapy at 17, 40, and 62 days after vaccination, and her clinical course was complicated by febrile neutropenia, diffuse abdominal pain, varicella?zoster infection, recurrent rash and respiratory distress. Extensive infectious workup, including next-generation sequencing of microbial cell-free DNA, was negative. Imaging showed worsening bilateral ground-glass opacities in the lungs as well as hepatic and splenic nodules. Unfortunately, her respiratory status declined rapidly, leading to her death 3 months after the vaccinations. An autopsy was performed. Microscopic examination of the lungs, liver, and pituitary gland showed multinucleated giant cells with cytoplasmic and intranuclear inclusions, which were confirmed as measles viral inclusions by immunohistochemical assay for measles virus. Furthermore, measles virus RNA was detected by reverse transcriptase polymerase-chain-reaction (RT-PCR) assay in lung tissue and characterized by vaccine-specific RT-PCR assay. The presence of a vaccine strain of measles was confirmed by sequence analysis and genotyping. No evidence of secondary infection or active lymphoma was found. It was described that this was a fatal case of vaccine-associated measles in a teenager with immune compromise secondary to lymphoma, with the diagnosis made post mortem. The reporter considered the event to be related to Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (MMR) (manufacturer unknown). A copy of the published article is attached as further documentation of the patient's experience.; Reported Cause(s) of Death: Disseminated Measles

Other Meds:

Current Illness: Hodgkin's lymphoma (stage IIA)

ID: 1747567
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: issue with autoimmune disease; This spontaneous report was received from a consumer concerning a female patient of unknown age. No information about the current condition, medical history or concomitant therapy was reported. On an unknown date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (dose, route and lot# were not reported) for prophylaxis. On an unknown date, the patient felt that ever since then she had issues with autoimmune disease (autoimmune disorder). The outcome of the event was not reported. Action taken with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) was not applicable. The causality between the event and quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) was not reported. Upon internal review, the event of autoimmune disorder was considered as medically significant.

Other Meds:

Current Illness:

ID: 1747570
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Suspected vaccination failure; still get shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had the Shingles shot and still experienced shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1747571
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: mild case of shingles, had shingles shot/ suspected vaccination failure; mild case of shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated his/her physician told that, could get a mild case of the shingles even after had shingles shot. The patient could vouch for Shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1747572
Sex: U
Age:
State: MO

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Fluarix vaccine which is expired; This case was reported by a pharmacist via sales rep and described the occurrence of expired vaccine used in an unspecified number of patients who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not applicable for this report. The physician reported that the staff was given expired dose of Fluarix season 2020-2021, which led to expired vaccine used. This case was linked with the case US2021201400, reported by same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021201400:same reporter

Other Meds:

Current Illness:

ID: 1747574
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: had both shots and shingles / suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, more than 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional case details were reported as follows: The reporter was patient's wife. The age at vaccination was not reported. The patient had both shots about two years before day of reporting and had a mild case of shingles this past spring. This case was considered as suspected vaccination failure, as details regarding laboratory test confirmation was unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1747575
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: out breaks since I got vaccine / suspected vaccination failure; out breaks, shingles; so painful; looks like a bad burn; peels; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain, burning skin and peeling. On an unknown date, the outcome of the vaccination failure, shingles, pain, burning skin and peeling were unknown. It was unknown if the reporter considered the vaccination failure, shingles, pain, burning skin and peeling to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had out breaks since he or she got the vaccine. It was so painful and nothing helps, after it looks like a bad burn and peels. The reporter mentioned that he or she never had vaccine. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1747576
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: had both shots this year, came back within 90 days / suspected vaccination failure; came back, shingles; sciatic nerve pain; pain in my back; pain in my leg; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, less than 3 months after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, sciatic neuralgia, back pain and leg pain. On an unknown date, the outcome of the vaccination failure, shingles, sciatic neuralgia, back pain and leg pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles, sciatic neuralgia, back pain and leg pain to be related to Shingles vaccine and Shingles vaccine. Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had both shots this year and it came back within 90 days due to sciatic nerve pain in my back and leg. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1747577
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: had this vaccine, shingles outbreak / suspected vaccination failure; shingles outbreak; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient's friend. The age at vaccination was not applicable for this report. The reporter stated that none of his or her friends who had this vaccine had been safe from getting a shingles outbreak. The reporter requested that there were antiviral drugs you could take, that greatly reduce the possibility of another shingles break out. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1747582
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: got the shingles vaccine then got shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were reported as follows: The case was reported by the patient's wife. The age at vaccination was not reported. The reporter's husband got the shingles vaccine then got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. No contact details were available.

Other Meds:

Current Illness:

ID: 1747586
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: have been vaccinated and had shingles / Suspected vaccination failure; I had shingles; have been vaccinated 3 times; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 3rd dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, not applicable after receiving Shingles vaccine and unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and extra dose administered. On an unknown date, the outcome of the vaccination failure, shingles and extra dose administered were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had shingles and had been vaccinated 3 times, which led to extra dose administered (for 3rd dose vaccine). This case was considered as suspected vaccination failure, as details regarding laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1747587
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: had both shingles shot, I have shingles now / suspected vaccination failure; shingles; painful; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine. Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had both shingles shot and had shingles now. It was painful, but his or her physician said that the shots kept him or her from being worse. The patient was glad that he or she got both shots. This case was considered as suspected vaccination failure, as details regarding laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1747588
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: very sore arm; sick; This case was reported by a consumer via (Facebook) interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis. On an unknown date, the patient received Shingles vaccine and Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Shingles vaccine and Influenza vaccine Quadrivalent unspecified season, the patient experienced sickness and pain in arm. On an unknown date, the outcome of the sickness was recovered/resolved and the outcome of the pain in arm was unknown. It was unknown if the reporter considered the sickness and pain in arm to be related to Shingles vaccine and Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient had the shingles vaccine and the flue shot at the same time.The nurse said it was ok. The patient was sick for two days also had very sore arm. The patient did not recommended it.

Other Meds:

Current Illness:

ID: 1747590
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: got the vaccine, got shingles / suspected vaccination failure; shingles in his eyes; hurting; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant) and pain. On an unknown date, the outcome of the vaccination failure, ophthalmic herpes zoster and pain were unknown. It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster and pain to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient's wife. The age at vaccination was not reported. The reporter stated that both got the vaccine a year before day of reporting. Now the patient got shingles in his eye. The vaccine did not stop it, it prevents it from being so severe. But he was a hurting unit. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1747591
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: suspected vaccination failure/Got shot and got shingles; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details provided were as follows: The patient self-reported this case. Age at vaccination was not reported. The patient received a shot of Shingles vaccine and experienced shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not be possible as no contact details available.

Other Meds:

Current Illness:

ID: 1747594
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: got the shot and broke out with shingles/suspected vaccination failure; shingles; blisters all over his arms; was in terrible pain; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, blister and pain. On an unknown date, the outcome of the vaccination failure, shingles and blister were unknown and the outcome of the pain was recovered/resolved. It was unknown if the reporter considered the vaccination failure, shingles, blister and pain to be related to Shingles vaccine. Additional details were provided as follows: This case was reported by patient's wife. The age at vaccination was not reported. The patient's wife reported that her husband never had shingles before. The doctor told the patient to take shingles vaccine and the patient broke out with shingles. The patient had blisters all over his arms. The patient was in terrible pain for 2 months. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1747596
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: suspected vaccination failure/got the vaccine and got them twice; got the vaccine and got them twice; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details provided were as follows: The case was reported by wife of the patient. Age at vaccination was not reported. The patient received a dose of Shingles vaccine and experienced Shingles twice. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not be possible as no contact details available.

Other Meds:

Current Illness:

ID: 1747597
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Had the shot and it didn't help; it didn't help; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The reporter stated that he/she had the shingles shot experienced shingles. It was reported that vaccine did not help. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747598
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The reporter stated that he/she had both shingles shot still experienced shingles. The reporter stated that hope vaccine works better for you all. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747599
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: suspected vaccination failure; I've had it 2xs; painful; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (the patient had shingles, before got the vaccine) and pain. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The reporter stated that he/she had shingles twice, Once before the vaccine and 14 years late r the patient had 2 vaccine shots and still experienced shingles. The patient stated that it was very, very painful both times. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747600
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Two shingles shots / After two years, shingles; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, 2 years after receiving Shingles vaccine and unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The reporter stated that he/she got the two shingles shots. Now after two years the patient had shingles. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747601
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Shingles a year after getting the shots; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, got Shingles a year after getting the shots.Never had it before that. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747602
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: had 2 shots and got shingles / still with relapses; got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The patient had the 2 shingles shots and got shingles so bad and still having relapses. The patient stated that don't get the shots. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747603
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: suspected vaccination failure; shingles on eye; shingles in my hair; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure, ophthalmic herpes zoster and shingles were unknown. It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster and shingles to be related to Shingles vaccine. Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The patient had the shingle shot and now the patient had a mild case of shingles above eye and in hair. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747606
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: took the vaccine currently have the shingles / suspected Vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, took the shingles vaccine, it was 2 shots, 8 weeks apart and currently now had the shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747608
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: had the shot, still got shingles/ suspected vaccination failure; shingles; so painful; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine. Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, had the shot and still got the shingles so painful. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747609
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The reporter stated that he/she had the shingles shot experienced shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747610
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: got the shot ended up with Shingles /suspected vaccination failure; Shingles; pain; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine. Additional details were provided as follows: The reporter was the patient's son or daughter. The age at vaccination was not reported. The reporter stated that, his or her mother got the shot and ended up with the king of shingles as her physician diagnosed with so much pain for a very long time. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747611
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Had the vax; got it anyway/Suspected vaccination failure; got it anyway; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The patient received shingle shot and got it anyway. The follow up would not be possible as no contact details were available. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule and time to onset and laboratory confirmation for shingles were unknown.

Other Meds:

Current Illness:

ID: 1747612
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Had both vaccine then got it again / suspected vaccination failure; got it again; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (had shingles vaccine 15 years ago and had shingles). On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, had both shingles vaccine and got shingles again. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided

Other Meds:

Current Illness:

ID: 1747613
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: had gotten the shingles shot. Then got shingles /suspected vaccination failure; shingles; This case was reported by a other health professional via interactive digital media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, before i retired from the hospital, met a lot of people who had gotten the shingles shot, then they got shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747614
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: suspected vaccination failure; have them 2 times; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The reporter stated that he/she had the shingles shot experienced shingles 2 times. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747615
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: suspected vaccination failure; shingles/Got the shot and still got shingle; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, several years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The reporter stated that he/she had the shingles shot experienced shingles few years later. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1747617
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Got it anyway! After shot/ suspected vaccination failure; Got it anyway!; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she got the shingles after Shingles sh ot. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1747618
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: shingles after she was vaccinated/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The age at vaccination was not reported. The patient got the shingles well after she was vaccinated with Shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1747619
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: suspected vaccination failure; shingles in her eye; blind in that eye; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant) and unilateral blindness (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure, ophthalmic herpes zoster and unilateral blindness were unknown. It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster and unilateral blindness to be related to Shingles vaccine. Additional details were provided as follows: The reporter was known to the patient. The age at vaccination was not reported. The reporter stated that, any vaccine has side effect but he/she know a lady(patient) who had the Shingle shot and then got shingles in her eye. The physician told the patient it was a side effect, blind in that eye now at the time of reporting. This case was considered as suspected vaccination failure, since the details regarding the completion of primary vaccination schedule, time to onset for event and laboratory confirmation for shingles were not provided.

Other Meds:

Current Illness:

ID: 1747622
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: both vaccines and still broke out with the rash./ suspected vaccination failure; broke out; both vaccines and still broke out with the rash.; This case was reported by a consumer via (Facebook) interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and rash. On an unknown date, the outcome of the vaccination failure, shingles and rash were unknown. It was unknown if the reporter considered the vaccination failure, shingles and rash to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had both Shingles vaccines and still broke out with the rash. The patient stated he/she had no pain with it though. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1747623
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: had the vaccine and he has shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a elderly male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated the patient had the Shingles vaccine and he has shingles in his 70's. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1747624
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The case was reported by the consumer for herself/himself. The age at vaccination was not reported. The reported stated that, he/she had the shingles after was vaccinated with Shingles vaccine. This case was considered as suspected vaccination failure, since the details regarding the completion of primary vaccination schedule, time to onset for event and laboratory confirmation for shingles were not provided.

Other Meds:

Current Illness:

ID: 1747646
Sex: M
Age: 86
State: FL

Vax Date: 01/25/2021
Onset Date: 09/11/2021
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: very warm; it became very sensitive; I had a fever for 2 days; my arm swelled up/it was the size of a golf ball; it was very red; it was painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (very warm), VACCINATION SITE HYPERAESTHESIA (it became very sensitive), PYREXIA (I had a fever for 2 days), VACCINATION SITE SWELLING (my arm swelled up/it was the size of a golf ball) and VACCINATION SITE ERYTHEMA (it was very red) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A, 013M20A and 037F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Renal disease and Heart disease, unspecified. Concomitant products included ATENOLOL, FELODIPINE, ESCITALOPRAM OXALATE (LEXAPRO), FISH OIL and DOXAZOSIN for an unknown indication. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Sep-2021, the patient experienced VACCINATION SITE WARMTH (very warm), VACCINATION SITE HYPERAESTHESIA (it became very sensitive), PYREXIA (I had a fever for 2 days), VACCINATION SITE SWELLING (my arm swelled up/it was the size of a golf ball), VACCINATION SITE ERYTHEMA (it was very red) and VACCINATION SITE PAIN (it was painful). On 13-Sep-2021, PYREXIA (I had a fever for 2 days) had resolved. On 18-Sep-2021, VACCINATION SITE WARMTH (very warm), VACCINATION SITE HYPERAESTHESIA (it became very sensitive), VACCINATION SITE SWELLING (my arm swelled up/it was the size of a golf ball), VACCINATION SITE ERYTHEMA (it was very red) and VACCINATION SITE PAIN (it was painful) had resolved. The treatment medication was unknown.

Other Meds: ATENOLOL; FELODIPINE; LEXAPRO; FISH OIL; DOXAZOSIN

Current Illness:

ID: 1747648
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 04/11/2021
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: NEUROPATHY PERIPHERAL; CONDITION AGGRAVATED; This spontaneous report received from a patient via a Regulatory Authority (ID: 1471293) concerned a 72-year-old female of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: sulfonamide allergy, high blood pressure, and peripheral neuropathy. The patient experienced drug allergy when treated with codeine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) frequency 1 total, dose was not reported, administered on 11-Apr-2021 for prophylactic vaccination. All required follow-up attempts have been made. The Batch number for COVID-19 Vaccine Janssen AD26.COV.2.S has not been provided. Concomitant medications included lisinopril, and nifedipine. On 11-Apr-2021, the patient stated that most intense bout of peripheral neuropathy in both legs and feet (condition aggravated) which patient frequently gets from degenerative disks and pinched nerves, from which patient had been suffering for years. The patient mentioned usually had one sided stabbing at night after patient lays down which lasts all night. The patient stated that the event lasted all night long but the intensity was hard to deal with. The patient mentioned that it stopped the next day but was really shocked. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from neuropathy peripheral, and condition aggravated on 12-Apr-2021. This report was serious (Other Medically Important Condition). Additional information was received on 28-Sep-2021.The following information was updated and incorporated into the case narrative: All required follow-up attempts have been made. The Batch number for COVID-19 Vaccine Janssen AD26.COV.2.S has not been provided.; Sender's Comments: V1: The follow up information in this version updates: All required follow-up attempts have been made. The Batch number for COVID-19 Vaccine Janssen AD26.COV.2.S has not been provided. This updated information does not alter the causality of previously reported event. 20210750560-COVID-19 VACCINE Ad26.COV2.S-Neuropathy Peripheral-This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: MEDICAL HISTORY, UNDERLYING DISEASE

Other Meds: LISINOPRIL; NIFEDIPINE

Current Illness: Blood pressure high; Peripheral neuropathy; Sulfonamide allergy

ID: 1747649
Sex: F
Age:
State: WI

Vax Date:
Onset Date: 05/01/2021
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: NEUROPATHY PERIPHERAL; CARDIAC MURMUR; SYNOVIAL CYST; FEELING HOT; PERIPHERAL COLDNESS; PARAESTHESIA; MALAISE; This spontaneous report received from a patient via a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System) (VAERS ID: 1464812) concerned a 50 year old female of an unspecified race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent condition included seasonal allergies. The patient had no illness at the time of vaccination. The patient experienced drug allergy in past when treated with Erythromycin for an unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, and expiry: unknown) dose was not reported, 1 total, administered on 02-APR-2021 to right arm for prophylactic vaccination. All required follow up attempts have been made. The batch number for covid-19 vaccine ad26.cov2.s has not been provided. Concomitant medications included ascorbic acid (Vitamin-C), curcuma longa rhizome (Turmeric extract), ergocalciferol (Vitamin-D), selenium, tocopherol (Vitamin-E) and Super Omega 3's, all for an unknown indication. On 01-MAY-2021 (reported as about a month after she received vaccination), she started to experience tingling, cold feelings (paraesthesia) in her feet and hands, her feet felt that they were breaking a cold sweat (peripheral coldness), it was very mild about 2 on a scale from 1-10. She noticed a lump on top of her right foot. The lump was diagnosed as a ganglion cyst (synovial cyst). Since 01-MAY-2021, she had peripheral neuropathy in feet and hands, and it spread to her legs and arms. The patient was diagnosed with a heart murmur (cardiac murmur). The doctor did not think that her symptoms were from the vaccine, when she first went to her doctor, so she had been waiting for things to clear up. The patient had another appointment with her doctor next week to discuss her symptoms. The patient was not aware if the vaccine was related to her symptoms. The patient never had either issue before or within the first 12 hours after the vaccination. It was reported that she felt so sick for about an hour like her blood was boiling in the body (feeling hot) and malaise. The patient stated that, the laboratory test would be done in the week of reporting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the cardiac murmur, feeling hot, malaise, neuropathy peripheral, peripheral coldness, paraesthesia and synovial cyst was not reported. This report was serious (Other Medically Important Condition). Additional information was received on 28-SEP-2021. All required follow-up attempts have been made. The Batch number for covid-19 vaccine ad26.cov2.s has not been provided; Sender's Comments: V1: Follow up information received in the current version is regarding all required follow-up attempts have been made. This updated information does not change the prior causality assessment of reported event. 20210751100-COVID-19 VACCINE Ad26.COV2.S-Neuropathy Peripheral. This event is considered un-assessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN D [ERGOCALCIFEROL]; SELENIUM; VITAMIN E [TOCOPHEROL]; TURMERIC [CURCUMA LONGA RHIZOME]

Current Illness: Seasonal allergy

ID: 1747652
Sex: M
Age:
State: FL

Vax Date:
Onset Date: 05/03/2021
Rec V Date: 09/30/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210602; Test Name: Angiogram; Result Unstructured Data: Artery blockage; Test Date: 20210602; Test Name: Stent placement; Result Unstructured Data: Unknown; Test Date: 20210602; Test Name: Electrocardiogram; Result Unstructured Data: Abnormal heart problem; Test Date: 20210602; Test Name: Catheterisation cardiac; Result Unstructured Data: Unknown

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: ANGIOGRAM ABNORMAL; CATHETERISATION CARDIAC; ELECTROCARDIOGRAM ABNORMAL; STENT PLACEMENT; CARDIAC DISORDER; ARTERIAL OCCLUSIVE DISEASE; CHEST DISCOMFORT; CHEST PAIN; This spontaneous report received from a patient via Regulatory Authority Agency; concerned a 60 year old male. The patient's height, and weight were not reported. The patient had no known allergies, no current illness and history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 07-APR-2021 in right arm for prophylactic vaccination. All required follow up attempts have been made. The batch number for covid-19 vaccine ad26.cov2.s has not been provided. Concomitant medications included curcuma longa anti-inflammatory, multiple vitamins, naproxen sodium pain reliver and additional vitamins. On 03-MAY-2021, A few weeks receiving the vaccination, patient started having chest pressure and pain (chest discomfort, chest pain). He was hospitalized (date unspecified) for 1 day. On 02-JUN-2021, he had severe pressure and pain in his chest. He went to the emergency room. An electrocardiogram indicated an abnormal heart problem (cardiac disorder). Angiogram revealed an artery blockage (arterial occlusive disease). A stent was inserted into the artery to resume blood flow (stent placement). Laboratory data included: Angiogram (NR: not provided) Artery blockage (Abnormal), Catheterizations cardiac (NR: not provided) Unknown, Electrocardiogram (NR: not provided) Abnormal heart problem, and Stent placement (NR: not provided) Unknown. The action taken with covid-19 vaccine ad26.cov2. s was not applicable. The patient recovered from cardiac disorder, arterial occlusive disease, chest discomfort, chest pain, angiogram abnormal, catheterization cardiac, electrocardiogram abnormal, and stent placement. This report was serious (Hospitalization Caused / Prolonged, and Life Threatening). Additional information was received on 28-SEP-2021. All required follow up attempts have been made. The batch number for covid-19 vaccine ad26.cov2.s has not been provided.; Sender's Comments: V1: Additional information in this version updates: All required follow up attempts have been made. The batch number for covid-19 vaccine ad26.cov2.s has not been provided. This updated information does not alter the causality of previously reported events. 20210751650-COVID-19 VACCINE AD26.COV2.S-Cardiac disorder, arterial occlusive disease, chest discomfort, chest pain, angiogram abnormal, catheterisation cardiac, electrocardiogram abnormal, stent placement. These events are considered unassessable. The events have a compatible/suggestive temporal relationship, are unlabeled, and have unknown scientific plausibility. There is no information on any other factors potentially associated with the events.

Other Meds: ALEVE; TURMERIC CURCUMIN [CURCUMA LONGA]

Current Illness:

ID: 1747654
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 04/01/2021
Rec V Date: 09/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210409; Test Name: Heart rate; Result Unstructured Data: increased; Test Name: COVID-19 virus test; Result Unstructured Data: Negative; Test Name: Blood test; Result Unstructured Data: No signs of infection; Test Name: COVID-19 virus test; Result Unstructured Data: Negative

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: DIZZINESS IS DEBILITATING; FEELING FLUEY; INCREASED HEART RATE; FEVER; RINGING IN EARS; HEAR HER HEART IN EARS LIKE STRONG PULSE; This spontaneous report received from a patient concerned a 71 year old female. The patient's height, and weight were not reported. The patient's past medical history included: runny nose, and concurrent conditions included: hashimoto's disease, and unspecified allergy, and other pre-existing medical conditions included: The patient reports no symptoms prior to vaccine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the patient experienced hear her heart in ears like strong pulse. On 08-APR-2021, the patient experienced ringing in ears. On 09-APR-2021, the patient experienced increased heart rate. On 09-APR-2021, the patient experienced fever. Laboratory data included: Heart rate (NR: not provided) increased. On MAY-2021, the patient experienced feeling fluey. On an unspecified date, the patient experienced dizziness is debilitating. Laboratory data (dates unspecified) included: Blood test (NR: not provided) No signs of infection, and COVID-19 virus test (NR: not provided) Negative, Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from increased heart rate, and fever on 10-APR-2021, hear her heart in ears like strong pulse, and ringing in ears on 03-JUN-2021, had not recovered from dizziness is debilitating, and the outcome of feeling fluey was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case is assessed as non-serious.

Other Meds:

Current Illness: Allergy; Hashimoto's disease

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am